Our Team

Our Founders

Stephen Hajduk, PhD

Founder & CSO

Extensive scientific track record spanning 47 years with over 100 publications on African Trypanosomes, including pioneering studies on ApoL1 toxicity in these parasites.

Eric DeJesus, PhD

Founder & CEO

Conceptualized and initially investigated ApoL1 as a therapeutic against human disease in 2010, with proven scientific track record of publications on ApoL1 toxicity.

Michael Cipriano, PhD

Founder & Vice President R&D

Conceptualized targeting ApoL1 with a bispecific antibody guided system, bringing a strong background in bioinformatics, research study design, and data analysis.